A. Cumaraswamy

Combined targeting of STAT3 and STAT5: a novel approach to overcome drug resistance in chronic myeloid leukemia

H. Maeda, T. Lion, M. Konopleva, 2017, Haematologica.

STAT5 Is a Key Regulator in NK Cells and Acts as a Molecular Switch from Tumor Surveillance to Tumor Promotion.

Z. Bago-Horvath, R. Moriggl, V. Sexl, 2016, Cancer discovery.

Pharmacologic inhibition of STAT5 in acute myeloid leukemia

Jisung Park, R. Moriggl, G. Keserű, 2018, Leukemia.

High activation of STAT5A drives peripheral T-cell lymphoma and leukemia

T. Rülicke, A. Chott, L. Kenner, 2019, Haematologica.

Inhibitors of Stat5 protein signalling

M. Minden, P. Gunning, D. Resetca, 2012 .

Progress towards direct inhibitors of Stat5 protein

P. Gunning, Abbarna A. Cumaraswamy, A. Cumaraswamy, 2012, Hormone molecular biology and clinical investigation.

Verdazyl Radicals as Substrates for Organic Synthesis: The Synthesis and Characterization of [12]-, [13]-, and [21]-Paraheteraphanes

M. Georges, G. Hamer, Abbarna A. Cumaraswamy, 2012 .

Nanomolar-Potency Small Molecule Inhibitor of STAT5 Protein

David E. Muench, X. Cheng, M. Minden, 2014, ACS medicinal chemistry letters.